Intestinal P-glycoprotein expression is multimodally regulated by intestinal ischemia-reperfusion

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 17, Issue 2, 2014, Pages 266-276

  Terada, Yusuke ^a   Ogura, Jiro ^a   Tsujimoto, Takashi ^a   Kuwayama, Kaori ^a   Koizumi, Takahiro ^a   Sasaki, Shunichi ^a   Maruyama, Hajime ^a   Kobayashi, Masaki ^a   Yamaguchi, Hiroaki ^a   Iseki, Ken ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; MULTIDRUG RESISTANCE PROTEIN; REACTIVE OXYGEN METABOLITE; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CACO 2 CELL LINE; CONTROLLED STUDY; DOWN REGULATION; DRUG BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE ISCHEMIA; INTESTINE MUCOSA PERMEABILITY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM; REPERFUSION INJURY; TIME TO MAXIMUM PLASMA CONCENTRATION; UPREGULATION; ANIMAL; BIOSYNTHESIS; BLOOD; CELL CULTURE; DOSE RESPONSE; GENETICS; HUMAN; INTESTINE; METABOLISM; PATHOLOGY; STRUCTURE ACTIVITY RELATION; WISTAR RAT;

ANIMALS; CACO-2 CELLS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROGEN PEROXIDE; INTESTINES; MALE; P-GLYCOPROTEIN; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; STRUCTURE-ACTIVITY RELATIONSHIP; TACROLIMUS;

EID: 84903778610     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3jg7d     Document Type: Article

References (31)

1. Murray, HW, Cohn ZA. Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation. J Exp Med, 1980; 152:1569-1609.
2. Varela D, Simon F, Riveros A, Jørgensen F, Stutzin A. NAD(P)H oxidase-derived H(2)O(2) signals chloride channel activation in cell volume regulation and cell proliferation. J Biol Chem, 2004; 279:13301-13304.
3. Rojkind M, Domínguez-Rosales JA, Nieto N, Greenwel P. Role of hydrogen peroxide and oxidative stress in healing responses. Cell Mol Life Sci, 2002; 59:1872-1891.
4. Granger DN, Korthuis RJ. Physiologic mechanisms of postischemic tissue injury. Annu Rev Physiol, 1995; 57:311-332.
5. Parks DA, Bulkley GB, Granger DN, Hamilton SR, McCord JM. Ischemic injury in the cat small intestine: role of superoxide radicals. Gastroenterology, 1982; 82:9-15.
6. Saugstad OD. Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease. Acta Paediatr, 1996; 85:1-4.
7. Omae T, Goto M, Shimomura M, Masuda S, Ito K, Okuda M, Inui K. Transient up-regulation of P-glycoprotein reduces tacrolimus absorption after ischemia-reperfusion injury in rat ileum. Biochem Pharmacol, 2005; 69:561-568.
8. Ogura J, Kobayashi M, Itagaki S, Hirano T, Iseki K. Alteration of Mrp2 and P-gp expression, including expression in remote organs, after intestinal ischemia-reperfusion. Life Sci, 2008; 82:1242-1248.
9. Tomita M, Takizawa Y, Kishimoto H, Hayashi M. Assessment of ileal epithelial P-glycoprotein dysfunction induced by ischemia/reperfusion using in vivo animal model. Drug Metab Pharmacokinet, 2008; 23:356-363.
10. Tomita M, Takizawa Y, Kishimoto H, Hayashi M. Effect of intestinal ischaemia/reperfusion on P-glycoprotein-mediated ileal excretion of rhodamine 123 in the rat. J Pharm Pharmacol, 2009; 61:1319-1324.
11. Ogura J, Maruyama H, Kobayashi M, Itagaki S, Iseki K. Pharmacokinetics of oral and intravenous administration of digoxin after intestinal ischemia-reperfusion. Biol Pharm Bull, 2010; 33:922-925.
12. Boros M, Takaichi S, Hatanaka K. Ischemic time-dependent microvascular changes and reperfusion injury in the rat small intestine. J Surg Res, 1995; 59:311-320.
13. Ogura J, Kuwayama K, Takaya A, Terada Y, Tsujimoto T, Koizumi T, Maruyama H, Fujikawa A, Takahashi N, Kobayashi M, Itagaki S, Hirano T, Yamaguchi H, Iseki K. Intestinal ischemia-reperfusion increases efflux for uric acid via paracellular route in the intestine, but decreases that via transcellular route mediated by BCRP. J Pharm Pharm Sci, 2012; 15:295-304.
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem, 1951; 193:265-275.
15. Ogura J, Fujikawa A, Maruyama H, Kobayashi M, Itagaki S, Iseki K. Alteration of P-gp expression after intestinal ischemia-reperfusion following 16-h fasting in rats. Yakugaku Zasshi, 2011; 131:453-462.
16. Yamaguchi H, Yano I, Saito H, Inui K. Pharmacokinetic role of P-glycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo. J Pharmacol Exp Ther, 2002; 300:1063-1069.
17. Khanna A, Rossman JE, Fung HL, Caty MG. Intestinal and hemodynamic impairment following mesenteric ischemia/reperfusion. J Surg Res, 2001; 99: 114-119.
18. Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med, 2009; 47:469-484.
19. Nagira M, Tomita M, Mizuno S, Kumata M, Ayabe T, Hayashi M. Ischemia/reperfusion injury in the monolayers of human intestinal epithelial cell line caco-2 and its recovery by antioxidants. Drug Metab Pharmacokinet, 2006; 21:230-237.
20. Noda T, Iwakiri R, Fujimoto K, Matsuo S, Aw TY. Programmed cell death induced by ischemia-reperfusion in rat intestinal mucosa. Am J Physiol, 1998; 274:G270-G276.
21. Ikeda H, Suzuki Y, Suzuki M, Koike M, Tamura J, Tong J, Nomura M, Itoh G. Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epithelium. Gut, 1998; 42:530-537.
22. Masuko T, Funayama Y, Naito H, Fukushima K, Shibata C, Takahashi K, Ogawa H, Ueno T, Hashimoto A, Miyazawa T, Nakagawa K, Matsuno S, Sasaki I. Measurement of phosphatidylcholine hydroperoxide in mild ischemia-reperfusion injury in rat intestine. Tohoku J Exp Med, 2002; 198:223-232.
23. Takizawa Y, Kishimoto H, Kitazato T, Tomita M, Hayashi M. Changes in the localization of ileal P-glycoprotein induced by intestinal ischemia/reperfusion. Biol Pharm Bull, 2011; 34:408-414.
24. Masuda S, Uemoto S, Goto M, Fujimoto Y, Tanaka K, Inui K. Tacrolimus therapy according to mucosal MDR1 levels in small-bowel transplant recipients. Clin Pharmacol Ther, 2004; 75:352-361.
25. Shimomura M, Masuda S, Saito H, Sakamoto S, Uemoto S, Tanaka K, Inui K. Roles of the jejunum and ileum in the first-pass effect as absorptive barriers for orally administered tacrolimus. J Surg Res, 2002; 103:215-222.
26. Hayashi M, Tomita M. Transcellular and paracellular contribution to transport processes in the colorectal route. Adv Drug Deliv Rev, 1997; 28:191-204.
27. Hayashi M, Tomita M. Mechanistic analysis for drug permeation through intestinal membrane. Drug Metab Pharmacokinet, 2007; 22:67-77.
28. Takizawa Y, Kishimoto H, Kitazato T, Tomita M, Hayashi M. Changes in protein and mRNA expression levels of claudin family after mucosal lesion by intestinal ischemia/reperfusion. Int J Pharm, 2012; 426:82-89.
29. Muzii L, Marana R, Marana E, Paielli FV, Meo F, Maussier ML, Sciarra M, Mancuso S. Evaluation of stress-related hormones after surgery by laparoscopy or laparotomy. J Am Assoc Gynecol Laparosc, 1996; 3:229-234.
30. Geier A, Dietrich CG, Trauner M, Gartung C. Extrahepatic cholestasis downregulates Oatp1 by TNF-alpha signalling without affecting Oatp2 and Oatp4 expression and sodium-independent bile salt uptake in rat liver. Liver Int, 2007; 27:1056-1065.
31. Venkataramanan R, Swaminathan A, Prasad T, Jain A, Zuckerman S, Warty V, McMichael J, Lever J, Burckart G, Starzl T. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet, 1995; 29:404-430.